Molecular detection of mononucleotide biomarkers of microsatellite instability in sporadic colorectal carcinoma patients with clinicopathological correlation

Authors

  • Wed Thamer Salman Al-Jumaili Al-Amal National Hospital for Cancer Management, Baghdad, Iraq.
  • Bassam Musa Sadik Al-Musawi Department of Pathology and Forensic Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.22317/jcms.v9i3.1348

Keywords:

Colorectal Neoplasms, Adenocarcinoma, Microsatellite Instability, Polymerase Chain Reaction, Iraq

Abstract

Objectives: To identify the frequency and types of microsatellite instability among a group of sporadic CRC patients and to correlate the findings with clinicopathological characteristics.

Methods: During an 8-month period, all patients with sporadic CRC who attended to two teaching hospitals in Baghdad, Iraq were recruited to this cross-sectional study regardless of age, sex, ethnicity, or tumor characteristics. Demographic, clinical, and histopathological features were recorded. DNA was extracted from FFPE-blocks of the resected tumors and normal tissues. PCR amplification of five microsatellite mononucleotide repeat loci (BAT25, BAT26, NR-21, NR-24, and MONO-27) and 2 pentanucleotide repeat control markers (Penta C and Penta D) was performed to determine the MSI status. Capillary electrophoresis and Genetic Analyzer 3500 (Applied Biosystem, Japan) were used to separate and examine the products. Data were analyzed by Genescan software (Promega, USA). Instability of two or more loci is considered MSI-H.

Result: In this study, ages of the 45 recruited patients ranged between 20-80 years, with a mean±SD of 55±12.3 years; of them, 31(68.9%) were ≥50 years; 25 (55.6%) were males. Rectal bleeding was the most frequent presenting feature [22 (48.9%)] patients; 23 (51.1%) of CRCs were located at recto-sigmoid region, 29 (64.4%) were T3 tumors, 34(75.5%) were non-mucinous adenocarcinoma, 39(86.7%) were moderately differentiated, 17 (37.8%) patients had stage III tumors; and 25 (55.5%) had lymphovascular invasion. MSI-H was seen in 5/45 (11.1%) patients; 3(60%) of them were ≥50 years, 4(80%) were males, 3(60%) were smokers, 2 (40%) presented with intestinal obstruction and altered bowel habits each; 4(80%) had T3 tumors, 3(60%) had mucinous adenocarcinomas [p=0.004], 2(40%) had stage II tumor and stage III each.

Conclusion: The frequency of MSI-H among the recruited patients with CRC was 5/45 (11.1%) and it was significantly associated with mucinous adenocarcinoma subtype. NR-24 and NR-21 were the most prevalent instable markers.

References

Arnold, M., et al., Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2017. 66(4): p. 683-691.

Baraaj, A. and H. Mahmood, Role Some Risk Factors : Age ,Sex And Lipid Profile In Colo-rectal Cancer In Iraqi Patient. Systematic Reviews in Pharmacy, 2021. 12: p. 1-5.

Mattiuzzi, C., F. Sanchis-Gomar, and G. Lippi, Concise update on colorectal cancer epidemiology. Ann Transl Med, 2019. 7(21): p. 609.

Al Dahhan, S.A. and F.H. Al Lami, Epidemiology of Colorectal Cancer in Iraq, 2002-2014. Gulf J Oncolog, 2018. 1(26): p. 23-26.

Douaiher, J., et al., Colorectal cancer-global burden, trends, and geographical variations. J Surg Oncol, 2017. 115(5): p. 619-630.

Binefa, G., et al., Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol, 2014. 20(22): p. 6786-808.

Xi, Y. and P. Xu, Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol, 2021. 14(10): p. 101174.

Alrubaie, A., N. Alkhalidi, and S. Abd-Alhusain, A clinical study of newly-diagnosed colorectal cancer over 2 years in a gastroenterology center in Iraq. Journal of Coloproctology, 2019. 39(3): p. 217-222.

De Rosa, M., et al., Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep, 2015. 34(3): p. 1087-96.

Grady, W.M. and S.D. Markowitz, The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci, 2015. 60(3): p. 762-72.

Zeinalian, M., et al., Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer. Adv Biomed Res, 2018. 7: p. 28.

Nguyen, L.H., A. Goel, and D.C. Chung, Pathways of Colorectal Carcinogenesis. Gastroenterology, 2020. 158(2): p. 291-302.

Webber, E.M., et al., Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. BMC Cancer, 2015. 15: p. 156.

Luchini, C., et al., ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol, 2019. 30(8): p. 1232-1243.

Söreide, K., et al., Microsatellite instability in colorectal cancer. British Journal of Surgery, 2006. 93(4): p. 395-406.

Loukola, A., et al., Microsatellite Marker Analysis in Screening for Hereditary Nonpolyposis Colorectal Cancer (HNPCC)1. Cancer Research, 2001. 61(11): p. 4545-4549.

Ali, E., et al., Jemperli (Dostarlimab-gxly): An unprecedented cancer trial. Ann Med Surg (Lond), 2022. 79: p. 104047.

Chung, C., Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation. 2022. 28(4): p. 850-869.

Shia, J., Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn, 2008. 10(4): p. 293-300.

Kamat, N., et al., Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. Oncology letters, 2013. 6(5): p. 1413-1420.

Kassem, N.M., et al., Clinicopathological features of Egyptian colorectal cancer patients regarding somatic genetic mutations especially in KRAS gene and microsatellite instability status: a pilot study. Egyptian Journal of Medical Human Genetics, 2019. 20(1): p. 20.

Faghani, M., et al., The Correlation between Microsatellite Instability and the Features of Sporadic Colorectal Cancer in the North Part of Iran. Gastroenterol Res Pract, 2012. 2012: p. 756263.

Deligonul, A., et al., Prognostic Significance of Microsatellite Instability in Turkish Patients with Stage II and III Colorectal Cancer. 2021. 5(1).

Rai, P.R., et al., A study on the frequency and clinicopathological correlates of mismatch repair-deficient colorectal cancer. J Cancer Res Ther, 2020. 16(Supplement): p. S183-s188.

Aykan, N.F., et al., Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial). Turk J Gastroenterol, 2015. 26(2): p. 145-53.

Ayyub, M.I., et al., Clinicopathological trends in colorectal cancer in a tertiary care hospital. Saudi Med J, 2002. 23(2): p. 160-3.

H.;, H.M., et al., Age and Gender in Relation to Colorectal Cancer in Najef Province: A Histopathological Study. Journal of Clinical and Laboratory Research, 2021. 2 (1): p. 10.

Alsanea, N., et al., Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies. Ann Saudi Med, 2015. 35(3): p. 196-202.

Alharbi, S.H., et al., Patterns and grades of presentation of colon cancer in Northern Saudi Arabia. Prz Gastroenterol, 2021. 16(3): p. 235-239.

Sharkas, G.F., et al., Colorectal Cancer in Jordan: Survival Rate and Its Related Factors. J Oncol, 2017. 2017: p. 3180762.

Kim, J.H. and G.H. Kang, Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. World J Gastroenterol, 2014. 20(15): p. 4230-43.

Goksu, S.Y., et al., Clinicopathologic variables and outcomes in elderly colorectal cancer patients with microsatellite instability and multiple primary malignancies. 2021. 39(15_suppl): p. e15516-e15516.

Abancens, M., et al., Sexual Dimorphism in Colon Cancer. 2020. 10.

Vargas Jentzsch, I., et al., Evolution of microsatellite DNA. 2013.

Slattery, M.L., et al., Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst, 2000. 92(22): p. 1831-6.

Fleming, M., et al., Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol, 2012. 3(3): p. 153-73.

Mohymen, N., B. Hanon, and A.S. Mahmood, The Correlation between Microsatellite Instability and the Features of Sporadic Colorectal Cancer in Sample of Iraqi Patients. JOURNAL OF ADVANCES IN BIOTECHNOLOGY, 2014. 4: p. 301-312.

Popat, S., R. Hubner, and R.S. Houlston, Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol, 2005. 23(3): p. 609-18.

Pritchard, C.C. and W.M. Grady, Colorectal cancer molecular biology moves into clinical practice. Gut, 2011. 60(1): p. 116-29.

Zwaenepoel, K., et al., Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer. The Journal of Molecular Diagnostics, 2020. 22(3): p. 386-395.

Downloads

Published

2023-06-26

How to Cite

Al-Jumaili, W. T. S. ., & Al-Musawi, B. M. S. . (2023). Molecular detection of mononucleotide biomarkers of microsatellite instability in sporadic colorectal carcinoma patients with clinicopathological correlation. Journal of Contemporary Medical Sciences, 9(3), 158–162. https://doi.org/10.22317/jcms.v9i3.1348